Collagen Sleep Latency Randomized Trial Evidence Table

Structured evidence table for Collagen Sleep Latency Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Collagen Sleep Latency Randomized TrialIt is important to gain an understanding of factors associated with poor quality of life as a patient’s perception of quality of life can predict treatment and intervention outcomes [].2Singh Prachi (2026)Effect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
Collagen Sleep Latency Randomized TrialWhile the relationship between insomnia, cardiometabolic risk, and quality of life is recognized, few physicians routinely conduct full sleep histories on their patients, and the patient satisfaction for insomnia treatment remains low [].2Singh Prachi (2026)Effect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
Collagen Sleep Latency Randomized TrialThe intervention duration was based on anecdotal evidence which suggested an acute same day effect on sleep.2Singh Prachi (2026)Effect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
Collagen Sleep Latency Randomized Trial1 2 3 Sleep and quality of life are closely entwined such that sleep disorders like insomnia are closely linked to poor quality of life [].2Singh Prachi (2026)Effect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
Collagen Sleep Latency Randomized TrialBeyond symptoms and impaired quality of life, OSA has been associated with major cardiometabolic and neurocognitive consequences.3Yuan Sai (2026)TGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities
Collagen Sleep Latency Randomized TrialProspective observational evidence links OSA to increased risks of stroke and mortality [].3Yuan Sai (2026)TGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities
Collagen Sleep Latency Randomized TrialOSA is also associated with neurocognitive impairment and affective symptoms, and growing literature connects OSA exposures to broader systemic comorbidity phenotypes [–].3Yuan Sai (2026)TGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities
Collagen Sleep Latency Randomized Trial1 2 3 4 5 8 Obstructive sleep apnea (OSA) is characterized by recurrent episodes of partial or complete upper-airway obstruction during sleep, leading to IH and sleep fragmentation (SF).3Yuan Sai (2026)TGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities
topicCollagen Sleep Latency Randomized Trial
claimIt is important to gain an understanding of factors associated with poor quality of life as a patient’s perception of quality of life can predict treatment and intervention outcomes [].
evidence level2
citationSingh Prachi (2026)
sourceEffect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
topicCollagen Sleep Latency Randomized Trial
claimWhile the relationship between insomnia, cardiometabolic risk, and quality of life is recognized, few physicians routinely conduct full sleep histories on their patients, and the patient satisfaction for insomnia treatment remains low [].
evidence level2
citationSingh Prachi (2026)
sourceEffect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
topicCollagen Sleep Latency Randomized Trial
claimThe intervention duration was based on anecdotal evidence which suggested an acute same day effect on sleep.
evidence level2
citationSingh Prachi (2026)
sourceEffect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
topicCollagen Sleep Latency Randomized Trial
claim1 2 3 Sleep and quality of life are closely entwined such that sleep disorders like insomnia are closely linked to poor quality of life [].
evidence level2
citationSingh Prachi (2026)
sourceEffect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
topicCollagen Sleep Latency Randomized Trial
claimBeyond symptoms and impaired quality of life, OSA has been associated with major cardiometabolic and neurocognitive consequences.
evidence level3
citationYuan Sai (2026)
sourceTGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities
topicCollagen Sleep Latency Randomized Trial
claimProspective observational evidence links OSA to increased risks of stroke and mortality [].
evidence level3
citationYuan Sai (2026)
sourceTGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities
topicCollagen Sleep Latency Randomized Trial
claimOSA is also associated with neurocognitive impairment and affective symptoms, and growing literature connects OSA exposures to broader systemic comorbidity phenotypes [–].
evidence level3
citationYuan Sai (2026)
sourceTGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities
topicCollagen Sleep Latency Randomized Trial
claim1 2 3 4 5 8 Obstructive sleep apnea (OSA) is characterized by recurrent episodes of partial or complete upper-airway obstruction during sleep, leading to IH and sleep fragmentation (SF).
evidence level3
citationYuan Sai (2026)
sourceTGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities

Source documents

  1. Effect of an herbal supplement on quality of life in participants with insomnia: A randomized placebo controlled cross-over pilot trial
  2. TGF‑β1 in obstructive sleep apnea: linking intermittent hypoxia, upper‑airway remodeling, and systemic comorbidities